Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesHematology/OncologyCommunity-Care Sylvant Prior Auth Coverage Update …
    Ask Trek AI about this page
    CurrentCommunity-CarePolicy N/A

    Sylvant

    Customize your policy alerts

    Sign up for all Community-Care policy alerts

    Know when Community-Care releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy defines coverage criteria, laboratory thresholds, dosing rounding, continuation criteria, quantity limits, authorization period, and applicable billing code for siltuximab (Sylvant) when used to treat multicentric Castleman disease (MCD)/iMCD.

    Policy Summary
    PayerCommunity-Care
    PolicySylvant
    Policy CodePolicy N/A
    Change Typeclarified
    Effective Date
    Last ReviewSep 1, 2022
    Next Review Date
    Key ActionSubmit documentation confirming MCD diagnosis per CDCN criteria, weight for dosing, and required lab results; include specialist consultation notes and clinical rationale if eligible dose is not rounded down.
    SourceLink
    POLICY UPDATE CHANGES

    Document includes dose rounding requirement and necessity for clinical rationale if eligible dose is not rounded down.

    1Covered Indications (MCD)
    1 yrAuthorization Period
    J2860Primary HCPCS Code

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.